Moreover, C3 knockdown reversed the sensitivity of tumor cells to PTX treatment and had no effect on proliferation, indicating that C3 regulated NSCLC PTX resistance in a C3a/C3aR/PI3K/AKT-independent manner. The gene discussed is C3AR1; the disease is neoplasm.